Cystic Fibrosis Seminar Series
Examples of recent cystic fibrosis seminar presentations (past 4-5 years) include the following:
Gergely Lukacs, M.D., Ph.D., McGill University, Montreal
"Folding and misfolding of CFTR: A cellular perspective"
Benjamin M. Gaston, M.D., University of Virginia Health Sciences Center
"S-Nitrosothiol Metabolism in Asthma and CF"
Gee Lau, Ph.D., University of Cincinnati College of Medicine
"Mechanisms of airway injury mediated by Pseudomonas aeruginosa exotoxin pyocyanin"
Laura Silo-Suh, Ph.D. and Sang-Jin Suh, Ph.D., Auburn University, Department of Biological Sciences
"Changing Faces of Pseudomonas aeruginosa: From Environment to the Cystic Fibrosis Lung"
Joseph Zabner, M.D., Department of Internal Medicine, University of Iowa
"The adenovirus receptor and adenovirus"
Terry Machen, Ph.D., Department of Molecular and Cell Biology, University of California, Berkeley
"Innate immune response in airway epithelia to P. aeruginosa: Role for CFTR?"
Christopher Karp, M.D., Cincinnati Children's Hospital Research Foundation
"Immunobiology of a novel genetic modifier of CF lung disease"
Ron Rubenstein, M.D., Ph.D., University of Pennsylvania School of Medicine
"More ramblings about CFTR and ENaC trafficking"
Marisa Sousa, Center of Human Genetics, National Institute of Health Dr Ricardo Jorge (Lisbon, Portugal)
"Mechanism of action in heterologous systems and native tissue efficacy of small molecules on mutant CFTR"
Sam Moskowitz, M.D., University of Washington
"Polymyxin resistance in cystic fibrosis: A tale of two (or more) Pseudomonas aeruginosa regulatory systems"
Karl Kunzelmann, M.D., University of Regensburg, Germany
"AMPK and CK2--Two Kinases that Regulate ENaC"
Stephen G. Aller, Ph.D., Scripps Research Institute
"The high resolution crystal structure of p-glycoprotein"
Robert Tarran, Ph.D., University of North Carolina Chapel Hill
"Estrogen and Cystic Fibrosis Lung Disease"
Timor Baasov, Ph.D., The Technion, Israel
"To Teach Old Drugs New Tricks: Redesign of Aminoglycosides for Treatment of Human Genetic Diseases"
James P. Kiley, M.S., Ph.D., Director, Division of Lung Diseases, NIH/NHLBI
"Update on Lung Related Activities at NHLBI"
Christine E. Bear, Ph.D., The Hospital for Sick Children, Canada
"Small Molecule Modulators Provide a Tool for Probing the Molecular Phenotype of Mutant CFTR"
Kasper Aanaes, M.D., University of Copenhagen
"The Paranasal Sinuses: A Focus for Bacterial Lung Infections in Cystic Fibrosis"
Mauri E. Krouse, Ph.D., Stanford University
"Airway Submucosal Glands: Normal and CF"
Mitchell Drumm, Ph.D., Case Western Reserve University
"GWAS for CF Modifiers"
Mike Stalvey, M.D., University of Massachusetts Medical School
"CF Bone Disease: Insights into a Growing Problem"
Michael J. Welsh, M.D., Howard Hughes Medical Institute, University of Iowa
"Insights into Cystic Fibrosis from a New Model"